- Title
- Pancreatic Islets Quality and Potency Cannot be Verified as Required for Drugs: Reflection on the FDA Review of a Biological License Application for Human Islets
- Creators
- Piotr Witkowski - University of ChicagoRoi Anteby - Harvard UniversityOyedolamu K Olaitan - Rush University Medical CenterRacheal C Forbes - Vanderbilt University Medical CenterSilke Niederhaus - University of Maryland, BaltimoreCamilo Ricordi - University of MiamiJeffrey H Fair - The University of Texas Medical Branch at GalvestonRobert C Harland - University of ArizonaCell Transplantation Committee of the American Society of Transplant Surgeons (ASTS)
- Publication Details
- Transplantation, Vol.105(12), pp.e409-E410
- Academic Unit
- Leadership Department; Miller School of Medicine; Diabetes Research Institute (DRI)
- Language
- English
- Resource Type
- Journal article
- PMID
- 34231527
- Record Identifier
- 991031714214402976
Journal article
Pancreatic Islets Quality and Potency Cannot be Verified as Required for Drugs: Reflection on the FDA Review of a Biological License Application for Human Islets
Transplantation, Vol.105(12), pp.e409-E410
2021-12-01
PMID: 34231527
Metrics
3 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.26 Diabetes
- 1.26.361 Islets
- Web Of Science research areas
- Immunology
- Surgery
- Transplantation
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites